Search Results - amy+trauernicht

1 Results

Sort By:

Endocrine Therapy Diagnostic for ER+ Breast Cancer

UT Health San Antonio seeks to partner with a diagnostic products company to develop and commercialize a clinical diagnostic with the potential to determine if a patient with estrogen receptor (ER) positive breast cancer is suitable for treatment with endocrine therapy (e.g., tamoxifen and/or the aromatase inhibitors anastrozole (Arimidex®), letrozole...

Published: 5/28/2024 | Inventor(s): Amy Trauernicht, Thomas Boyer

Keywords(s): Biologics, Drugs

Category(s): Diagnostics > Assay, Clinical Specialty > Oncology, Clinical Specialty > Women's Health